Search

everythinglearnresearchcommunity

for

Search:↓

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Stem-cell therapy shows promise for skin conditions but needs more research.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Pig blood can be used to mass-produce stable, low-cost platelet dry powder for medical use.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.